| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $356K | -59.2% | -49.6% |
| SG&A Expense | $968K | +8.2% | -12.3% |
| Operating Income | -$1.8M | +4.5% | +2.0% |
| Pre-tax Income | -$2.8M | -56.5% | -45.7% |
| Net Income | -$2.8M | -56.5% | -45.7% |
| EPS (Basic) | -$2.50 | -1288.9% | -125.2% |
| EPS (Diluted) | -$2.50 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Short-term Investments | $3.1M | -14.2% | -67.3% |
| Current Assets | $11.1M | +116.3% | -7.3% |
| Total Assets | $37.2M | +117.1% | +54.9% |
| Current Liabilities | $6.5M | +17.7% | -6.5% |
| Total Liabilities | $15.9M | +186.7% | +127.7% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.9M | — | — |
| Investing Cash Flow | $3.2M | — | — |
| Financing Cash Flow | $9.4M | — | — |
| -1288.9% |
| -125.2% |
| $14.3M |
| +171.4% |
| -14.6% |